Stay updated on TNT Clinical Trial: Talimogene + Nivolumab + Trabectedin
Sign up to get notified when there's something new on the TNT Clinical Trial: Talimogene + Nivolumab + Trabectedin page.
Latest updates to the TNT Clinical Trial: Talimogene + Nivolumab + Trabectedin page
- Check6 days agoChange DetectedNo significant updates to core study content detected; changes appear limited to formatting and minor wording in non-critical sections. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded a new Locations section listing California as a study site. Removed the California Locations entry and the HHS Vulnerability Disclosure text, and updated the page revision from v3.3.2 to v3.3.3.SummaryDifference0.2%
- Check28 days agoChange DetectedThe screenshots show no significant changes to core study content; only metadata such as the last update date appears to be different. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check35 days agoChange DetectedThere are no substantive changes to the core study information between the two screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check49 days agoChange DetectedPublication section wording was revised from 'are about the study results' to 'are about the results of the study,' a minor textual update to the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check56 days agoChange DetectedThe banner regarding government funding and operating status was removed from the page.SummaryDifference0.5%
Stay in the know with updates to TNT Clinical Trial: Talimogene + Nivolumab + Trabectedin
Enter your email address, and we'll notify you when there's something new on the TNT Clinical Trial: Talimogene + Nivolumab + Trabectedin page.